Followers | 1084 |
Posts | 27341 |
Boards Moderated | 11 |
Alias Born | 01/11/2016 |
Tuesday, June 16, 2020 8:19:43 AM
Recent IDYA News
- IDEAYA Announces Webcast to Report Interim Phase 2 Data for Darovasertib and Regulatory Update from FDA Type C Meeting in Neoadjuvant Uveal Melanoma on Monday, September 23, 2024 • PR Newswire (US) • 09/22/2024 01:00:00 PM
- IDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice President, General Counsel • PR Newswire (US) • 09/18/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 08/30/2024 10:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 09:16:46 PM
- IDEAYA Biosciences to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference • PR Newswire (US) • 08/26/2024 10:00:00 AM
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 08/23/2024 10:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 09:08:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:13:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 10:04:25 AM
- IDEAYA Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update • PR Newswire (US) • 08/06/2024 10:00:00 AM
- 百奧賽圖宣布與IDEAYA Biosciences就具有同類首創潛力的B7H3/PTK7拓撲異構酶抑制劑有效負載雙特異性ADC專案達成選擇權和授權合約 • Business Wire • 07/31/2024 11:56:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2024 10:03:19 AM
- 百奥赛图宣布与IDEAYA Biosciences就具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性ADC项目达成选择权和许可协议 • Business Wire • 07/31/2024 10:00:00 AM
- Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program • Business Wire • 07/31/2024 10:00:00 AM
- Biocytogen Announces Option and License Agreement with IDEAYA Biosciences for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program • Business Wire • 07/31/2024 10:00:00 AM
- IDEAYA Biosciences Announces Option and License Agreement for Potential First-in-Class B7H3/PTK7 Topo-I-Payload Bispecific ADC Program with Biocytogen • PR Newswire (US) • 07/31/2024 10:00:00 AM
- IDEAYA Biosciences to Participate in Upcoming August 2024 Investor Relations Event • PR Newswire (US) • 07/29/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 08:12:29 PM
- IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares • PR Newswire (US) • 07/11/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/10/2024 09:17:24 PM
- IDEAYA Announces Pricing of Public Offering • PR Newswire (US) • 07/10/2024 02:26:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/09/2024 09:08:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:11:00 PM
- IDEAYA Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • PR Newswire (US) • 07/09/2024 08:08:00 PM
- Paramount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More News • IH Market News • 07/08/2024 10:37:52 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM